KevinDMullenMD

PubMed

• 354 citations
  Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the European Association for the Study of the Liver and the American Association for the St...
  Hendrik Vilstrup, Piero Amodio, Jasmohan S. Bajaj, Juan Cordoba, Peter Ferenci
  Journal of Hepatology. 2014-09-01
• 1457 citations
  Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vie...
  Peter Ferenci, Alan H. Lockwood, Kevin D. Mullen, Ralph E. Tarter, Karin Weissenborn
  Hepatology. 2002-03-01
• 263 citations
  Surprisingly small effect of antiviral treatment in patients with hepatitis C.
  Yngve Falck-Ytter, Hemangi Kale, Kevin D. Mullen, Steedman A. Sarbah, Lucian Sorescu
  Annals of Internal Medicine. 2002-02-19

Journal Articles

• HE treatments are difficult to study  
  Mullen KD, GI & Hepatology News, 4/1/2014
• Rifaximin is safe and well tolerated for long term maintainence of remission from Overt Hepatic Encephalopathy  
  Mullen KD, Sanyal AJ, Bass NM et al, Clin Gastroenterol Hepatol, 12/1/2013
• Pleural Effusion and Pseudocyst  
  Gulati D,Khanna G, Mullen KD, Clin Gastro & Hepatol, 1/1/2013
• Cognitive Dysfunction is associated with poor socioeconomic status in patients with cirrhosis  
  Bajaj JS, Riggio O, Alampati S, Prakash R, Gioio S, Onoro E, Piazza N, Noble MB, Mullen KD, Clin Gastroenterol Hepatol, 1/1/2013
• Theories of the pathogenesis of Hepatic Encephalopathy  
  Jones EA, Mullen KD, Clin Liver Dis, 1/1/2012
• Management of overt Hepatic Encephalopathy  
  Mullen KD, Prakash RK, Clin Liver Dis, 1/1/2012
• New Perspectives in HE  
  Mullen KD, Prakash RK, Clin Liver Dis, 1/1/2012
• Recurrent intentional foreign body ingestion An Endoscopists dilemma  
  Atluri D, Veluru C, Chopra A, Mullen KD, Gastroenterol & Hepatol, 1/1/2012
• Alteration in body composition in the portacaval anastamosis rat is mediated by increasedexpression of myostatin  
  Dasarathy S, Muc S, Runkana A, Mullen KD, Kaminsky-Russ K, McCullough AJ, Am J Physiol Gastrointest Liver Physiol, 10/1/2011
• Is poor quality of life always present with minimal hepatic encephalopathy?  
  Prakash RK, Mullen KD, Liver Int, 8/1/2011
• Racial differences in hepatitis C treatment eligibility  
  Melia MT, Muir AJ, McCone J, Shiffman ML, King JW, Herrine SK, Galler GW, Bloomer JR, Nunes FA, Brown KA, Mullen KD, Ravendhran N, Ghalib RH, Boparai N, Jiang R, Novie..., Hepatology, 7/1/2011
• Salmonella enteritidis liver abscess  
  Sheikh I, Sievers C, Mullen KD, Ann Hepatol, 6/1/2011
• Rifaximin for the treatment of hepatic encephalopathy  
  Mullen KD, Prakash R, Expert Rev Gastroenterol Hepatol, 12/1/2010
• Dyslipidemia and lipoprotein profiles in patients with inflammatory bowel disease  
  Sappati Biyyani RS, Putka BS, Mullen KD, Clin Lipidol, 11/1/2010
• Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate  
  Sulkowski MS, Shiffman ML, Afdhal NH, Reddy KR, McConeJ, Lee WM, Herrine SK, Harrison SA, Poordad FF, Koury K, Deng W, Noviello S, Pedicone LD, Brass CA, Albrecht JK, ..., Gastroenterol, 11/1/2010
• Medscape Mechanisms, diagnosis and management of hepatic encephalopathy  
  Prakash R, Mullen KD, Nat Rev Gastoenterol Hepatol, 9/1/2010
• The treatment of patients with hepatic encephalopathy: Review of the latest data from EASL 2010  
  Mullen KD, Gastroenterol Hepatol (NY), 7/1/2010
• Unilateral pleural effusion – but where from?  
  Gulati D, Mullen KD, Magrey M, Lancet, 6/1/2010
• Skin rash during chronic hepatitis C therapy  
  Veluru C, Atluri D, Chadalavada R, Burns E, Mullen KD, Gastroenterology Hepatol (NY), 5/1/2010
• The treatment of hepatic encephalolpathy in cirrhotic patients  
  Sanyal J, Mullen KD, Bass N, Gastroenter and Hepatol, 1/1/2010
• A levitating tattoo in a hepatitis C patient on treatment  
  Atluri D, Iduru S, Veluru C, Mullen KD, Liver Int, 1/1/2010
• Reversibility of hepatic encephalopathy after liver transplantation  
  Atluri D, Asgeri M, Mullen KD, Metabolic Brain Dis, 1/1/2010
• Nutrition in hepatic encephalopathy  
  Chadalavada R, Sappati Biyyani, Maxwell J, Mullen KD, Nutr Clin Pract, 1/1/2010
• The disposition of hepatitis C antibody positive patients in an urban hospital  
  Putka B, Mullen KD, Birdi S, Merheb M, J Viral Hepat, 11/1/2009
• Skin lesions in a patient on chronic Hepatitis C therapy  
  Hisamuddin K, Veluru C, Mullen KD, Clin Gastroenterol Hepatol, 6/1/2009
• Join now to see all

Books/Book Chapters

• Clinical Gastroenterology 
  Chapter: Nomenclature , and Classification of Hepatic Encephalopathy. 
  Page 1 - 4Mullen KD, Prakash RKHumana Press2012
• Clinical Gastroenterology 
  Chapter: The role of Natural Benzodiazepines receptor Ligands in Hepatic C Encephalopathy. 
  Page 71 - 93Jones EA, Mullen KDHumana Press2012
• Clinical Gastroenterology 
  Chapter: Future of Hepatic Encephalopathy. 
  Page 241 - 243Mullen KD, Prakash RKHumana Press2012
• Clinical Gastroenterology 
  Chapter: Antibiotic treatment for Hepatic Encephalopathy. 
  Page 159 - 164Mullen KD, Prakash RKHumana Press2012
• Clinical Gastroenterology 
  Chapter: Liver transplantation and Hepatic Encephalopathy. 
  Page 233 - 239Atluri DK, Mullen KDHumana Press2012
• Schiffs Disease of Liver. 
  Chapter: Chapter 18: Hepatic Encephalopathy. 
  Prakash R, Mullen KD2011
• Handbook of Liver Disease 
  Chapter: Chapter 13: Hepatic Encephalopathy. 
  Prakash R, Mullen KDEditors: Friedman Lawrence S, Emmet Keefe B.2011
• New Encyclopedia of Neuroscience 
  Chapter: Hepatic encephalopathy. 
  Basile AS, Mullen KD2009
• Practical management of Liver Disease. 
  Chapter: Chapter 7: Wilson’s Disease. 
  Wakim-Fleming J, Mullen KD2008
• Hepatology: A Textbook of Liver Disease. 
  Chapter: Hepatic Encephalopathy. 
  Page 1 - 21Mullen KEditors: Boyer, Manns & Wright.ElsevierEdition 5th,2006
• Hepatic Encephalopathy and Nitrogen Metabolism. 
  Chapter: Evidence-based medicine and HE treatment. 12th ISA Symposium. Schlossberg, Germany, 2005. 
  Page 505 - 512Mullen KDEditors: D. Haussinger, G. Kircheis and F. Schliess.Springer, Dordrecht, The Netherlands2005
• 11th ISA Symposium. Encephalopathy and nitrogen metabolism in liver failure. 
  Chapter: Pathogenesis of hepatic encephalopathy. 
  Page 177 - 184Mullen KDEditors: Jones EA, Meizer AJ, Chamaleau AFM.Kluwer Academic Publishers2003
• 11th ISA Symposium. Encephalopathy and nitrogen metabolism in liver failure. 
  Chapter: Experience with neuropsychiatric complication of interferon based therapy in chronic viral hepatitis. 
  Page 153 - 158Mullen KDEditors: Jones EA, Meizer AJ, Chamaleau AFM.Kluwer Academic Publishers2003
• Comprehensive Clinical Hepatology 
  Chapter: Hepatic encephalopathy. 
  Mullen KDEditors: O’Grady, Lake & Howdle.Mosby2000
• Diseases of the Liver 
  Chapter: Hepatic encephalopathy. 
  Page 545 - 582Mullen KD, Dasarathy SEditors: Schiff et al.LippincottEdition 8th,1999
• Medical Management of Liver Disease 
  Chapter: Management of hepatic encephalopathy. 
  Page 511 - 521Mullen KD, Kyprianou A, Sarbah SAEditors: Edward L. Krawitt.Marcel Dekker Inc.1999
• Liver Disease: Diagnosis and Management. 
  Chapter: Complications of cirrhosis: Portosystemic encephalopathy. 
  Page 251 - 260Mullen KD, Sarbah SA, Kyprianou AEditors: BR Bacon and AF DiBisceglie.Churchill LivingstoneEdition 1st,1999
• Therapy of Digestive Disorders. 
  Chapter: Therapy of portosystemic encephalopathy. 
  Page 385 - 397Dasarathy S, Mullen KDEditors: M. Wolfe et al.W.B. Saunders1999
• Handbook of Liver Disease. 
  Chapter: Hepatic encephalopathy. 
  Page 185 - 195Mullen KEditors: L.S. Friedman, E.B. Keefe.Churchill Livingstone1998
• Intensive Review of Internal Medicine 
  Chapter: Hepatology 
  Page 573 - 577Mullen KDEditors: Stoller, Ahmad & Longworth.Williams and Wilkins1998
• NewCastle on Tyne. Advances in hepatic encephalopathy and metabolism in liver disease. 
  Chapter: "Endogenous" benzodiazepines may originate from the intestines. 9th International Ammonia Symposium. 
  Page 239 - 244Mullen KD, Gacad R, Kaminsky-Russ K, Aronson L, Gregory CEditors: C. Record, H. Mardini.1997
• NewCastle Upon Tyne. Advances in hepatic encephalopathy and metabolism in liver disease. 
  Chapter: Reducing brain glutamine synthesis does not improve behavior in portacaval shunted rats. 9th International Ammonia Symposium. June 1996. 
  Page 423 - 426Mullen KD, Gacad R, Kaminsky-Russ KEditors: C. Record, H. Mardini.1997
• Advances in hepatic encephalopathy and metabolic nitrogen exchange. 
  Chapter: Effect of a casein purified diet on growth of portacaval shunted rats. Proceedings of the 8th International Ammonia Symposium. 
  Page 293 - 303Teran JC, Mullen KD, Conjeevaram H, Kaminsky-Russ K, McCullough AJEditors: Capocaccia L, Merli M, Rigglo O.CRC Press, Boca Raton, FL1995
• Advances in hepatic encephalopathy and metabolic nitrogen exchange. 
  Chapter: Optimal animal models in the study of hepatic encephalopathy and nitrogen. 
  Page 279 - 292Mullen KDEditors: Capocaccia L, Merli M, Rigglo O.CRC Press, Boca Raton, FL1995
• Proceeding of the "International Symposium on Cirrhosis, Hyperammonemia and Hepatic Encephalopathy." Hepatic Encephalopathy, hyperammonemia and ammonia toxicity. 
  Chapter: Animal models of hepatic encephalopathy and hyperammonemia. 
  Page 1 - 10Mullen KD, Birgisson S, Gacad R, Conjeevaram HSEditors: Felipo V, Grisolia S.Plenum Press, Valencia, Spain; New York, NY1994
• Join now to see all

Abstracts/Posters

• What is the Diagnostic Utility of an Abdominal CT Scan in patients admitted to a Medical Service with Non-Specific Abdominal Pain?
  Imran Sheikh, Maya Merheb, Amy Soloman, Wen Zhang, Catherine Curley, Kevin Mullen, DDW, 1/1/2011
• The protective effect of Rifaximin (1100 mg daily) from hepatic encephalopathy observed in a double blind placebo-controlled study is substantiated and durable over lo...
  Poordad F, Bass N, Sanyal A, Sheikh M, Mullen KD, Sigal S, Frederick T, Brown RS, Joshi S, Merchant K, Huang S, Shaw A, Bortey E, Forbes WP, AASLD, 1/1/2009
• Intense pruritis requiring hospitalization secondary to EBV hepatitis.
  Agarwal S, Jain A, Mullen KD, ACG, 1/1/2009
• Inflammatory Pseudotumor of the Lung with Primary Sclerosing Cholangitis.
  Anna K, Jain A, Mullen KD, ACG, 1/1/2009
• Spectrum of Psychiatric Diagnosis Associated with High-Risk Behaviour in an Inner City Hepatitis C Patient Population.
  Anna K, Sappati RS, Prakash R, Mullen KD, ACG, 1/1/2009
• Is obesity a risk factor for anemia?
  Anna K, Sappati-Biyyani RS, Veluru C, Mullen KD, ACG, 1/1/2009
• Is modafanil the answer to hepatitis C induced fatigue?
  Iduru S, Ganesan S, Shah N, Mullen KD, ACG, 1/1/2009
• Rare presentation of a rare side effect.
  Iduru S, Shah N, Mullen KD, ACG, 1/1/2009
• Hepatitis C patients have larger Colonic Adenomas.
  Prakash R, Shah N, Mullen KD, ACG, 1/1/2009
• Superior Colorectal Cancer Screening in Hepatitis C Population.
  Prakash R, Shah N, Putka B, Mullen KD, ACG, 1/1/2009
• Rifaximin has a favourable long-term safety profile for maintenance of remission from Overt Hepatic Encephalopathy.
  Sheikh M, Bass N, Sanyan A, Poordad F, Mullen KD, Sigal S, Frederick T, Bhandari BR, Vermuru R, Huang S, Merchant K, Shaw A, Bortey E, Forbes, ACG, 1/1/2009
• Colonoscopy in Diabetic Patients. Endoscopists worst nightmare.
  Veluru C, Atluri D, Mullen KD, ACG, 1/1/2009
• Pre-endoscopic Proton Pump Inhibitors in Non-variceal Upper Gastro-intestinal Bleeding; Continuous Infusion vs Bolus.
  Prakash R, Iduru S, Soloman A, Shah N, Putka B, Mullen KD, Ferguson R, DDW, 1/1/2009
• Sustained viral response (SVR) and predictors of response in African American (AA) patients in the Ideal Phase 3 B study.
  McCone J, Hu, K, McHutchison J, Shiffman M, King J, Herrine S, Galler G, Aulkowski M, Niunes F, Brown K, Gordon S, Mullen K, et al, AASLD, San Francisco, CA, 1/1/2008
• Probability of sustained viral remission is associated with the magnitude of HCV RNA reduction at Week 4 of treatment and Peg-interferon and Ribavirin: Results of the ...
  Sulkowski M, Vierling J, Brown, K Flamm S, Kwo P, Mullen K, et al, AASLD, San Francisco, CA, 1/1/2008
• Current opinion regarding the utilization of liver biopsies in the management of Hepatitis C. A National Survey.
  Wienerman D, Mullen KD, AASLD, San Francisco, CA, 1/1/2008
• Vena Caval C-clamping. An improved portacaval anastomosis Technique in Rats.
  Asgeri AM, Sanabria J, Nader ND, Mullen KD, AASLD, 1/1/2008
• Assessment of endoscopic skills of gastroenterology trainees by self-evaluation, endoscopy nurses and attendings. Correlation between three sides of the story.
  Sanaka MR, Mullen KD, Super D, Naughton A, Ferguson DR, McCullough AJ, Gastrointestinal Endoscopy, 1/1/2005
• The impact of endoscopy nurse on colonoscopy completion rates.
  Sanaka MR, Shah N, Mullen KD, Amini S, McCullough AJ, Gastrointestinal Endoscopy, 1/1/2005
• Afternoon colonoscopies have higher failure rates compared to morning colonoscopies.
  Shah N, Sanaka MR, Mullen KD Amini S, McCullough AJ, Gastrointestinal Endoscopy, 1/1/2005
• Comparison of polyp detection rates during colonoscopy by attending alone versus trainee plus attending staff: Are two people better than one?
  Shah N, Sanaka MR, Mullen KD, Amini S, McCullough AJ, Gastrointestinal Endoscopy, 1/1/2005
• Diabetes but not obesity is associated with advanced fibrosis in patients with non-alcoholic fatty liver disease.
  Dasarathy S, Thiruppathi S, Dodig M, Liu Y, Khiyami A, Petrelli M, Mullen KD, McCullough A, AGA, New Orleans, LA, 1/1/2004
• Natural history of hepatic encephalopathy in chronic liver disease.
  Dasarathy S, Mullen KD et al, 11th International Symposium on Hepatic Encephalopathy and Nitrogen Exchange, Amsterdam, Netherlands, 1/1/2002
• Experience with neuropsychiatric complications of interferon-based therapy in chronic viral hepatitis.
  Mullen KD, 11th International Symposium on Hepatic Encephalopathy and Nitrogen Exchange, Amsterdam, Netherlands, 1/1/2002
• Pathogenesis of hepatic encephalopathy.
  Mullen KD, 11th International Symposium on Hepatic Encephalopathy and Nitrogen Exchange, Amsterdam, Netherlands, 1/1/2002
• Join now to see all

Lectures

• Lessons learned from over 25 years of antiviral therapy for chronic Hepatitis C. 
  3/1/2014
• Update on Hepatic Encephalopathy. 
  Jakarta, Indonesia - 10/1/2013
• Lessons learnt from 25 years of treating Chronic Hepatitis C. 
  Metrohealth Medical Center - 4/1/2012
• Is Hepatic Encephalopathy Reversible? 
  Mainz, Germany - 5/1/2009
• Hepatic Encephalopathy. 
  Framingham, MA - 5/1/2008
• Measuring Hepatic Encephalopathy. 
  Padua, Italy - 4/1/2008
• 20 years Experience in Treating Chronic Hepatitis C. 
  Aleppo, Syria - 7/1/2007
• Placebo trials are feasible and ethical in HE treatment. 
  Dresden, Germany - 6/1/2006
• Evidence Based Medicine and HE Treatment. 
  Schlossberg, Germany - 1/1/2005
• Management of Acute Hepatitis C. 
  MetroHealth Medical Center - 5/1/2004
• Artificial Liver Support. 
  Bremen, Germany - 6/1/2003
• Pathogenesis of Hepatic Encephalopathy” and “Neurological Complications of Interferon Therapy. 
  Amsterdam - 5/1/2002
• World Congress of Gastroenterology. 
  Bangkok, Thailand - 2/1/2002
• Treatment of Chronic Hepatitis C 
  MetroHealth Medical Center - 2/1/2001
• Design of Clinical Trials in Hepatic Encephalopathy. 
  Istanbul - 5/1/1999
• Terminology of Hepatic Encephalopathy 
  Vienna, Austria - 9/1/1998
• HE after TIPS – Treatment Option 
  Vienna, Austria - 9/1/1998
• Terminology of Hepatic Encephalopathy. (Invited Speaker) 
  New Castle, England - 5/1/1996
• Animal Models of Hepatic Encephalopathy and Hyperammonemia. (Invited Speaker) 
  Valencia, Spain - 1/1/1994
• Animal Models of Liver Disease. (Invited Speaker) 
  Rome, Italy - 5/1/1993
• New approaches to the Management of Chronic Hepatic Encephalopathy. (Invited Speaker) 
  Chicago, IL - 11/1/1992
• Hepatic Encephalopathy. Invited Speaker 
  Rush-Presbyterian, Chicago, IL - 11/1/1991
• Interferon Treatment of viral Hepatitis 
  Boston, MA - 9/1/1991
• Endogenous Benzodiazepines in Human Hepatic Encephalopathy. (Invited Speaker) 
  Bristol, United Kingdom - 6/1/1991
• Endogenous Benzodiazepines in Human Hepatic Encephalopathy. 
  Snowmass, CO - 1/1/1990
• Join now to see all

Other

• Treatment Options in Hepatic Encephalopathy 
  Waghray N, Waghray A, Mullen K, Curr Treat Options Gastroenterology EPUB
  3/1/2014
• Continuing Medical Education in Echocardiography 
  Fan P, Pantham G, Waghray N, Einstadter D, Finkelhor RS, Mullen KD, EPUB
  11/30/2013
• Hepatic Encephalopathy. 
  Mullen KD, AGA Postgraduate Course Syllabus, Philadelphia, PA
  1/1/1995
• New approaches to the management of chronic hepatic encephalopathy. 
  Mullen KD, AASLD Postgraduate Course Syllabus
  1/1/1992
• Join now to see all